Expert Opinion on Therapeutic Targets 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 8, 2024 Category: Drugs & Pharmacology Authors: Ilan BruchimIlaria CapassoAriel PolonskyShilhav MeiselVanda SalutariHaim WernerDomenica LorussoGiovanni ScambiaFrancesco Fanfania Gynecology and Gynecologic Oncology Department, Hillel Yaffe Medical Center, Hadera, Israelb Gynecology Laboratory, Departmen Source Type: research
Kv1.3 in the spotlight for treating immune diseases
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 6, 2024 Category: Drugs & Pharmacology Authors: Mar ía Navarro-PérezJesusa CaperaAnna Benavente-GarciaSilvia CassinelliMagalí Colomer-MoleraAntonio Felipea Molecular Physiology Laboratory, Departament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina (IBUB), Universitat de Barcelona, B Source Type: research
Role of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategies
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 5, 2024 Category: Drugs & Pharmacology Authors: Mattia GalliDominick J. Angiolilloa Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italyb Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA Source Type: research
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 18, 2024 Category: Drugs & Pharmacology Authors: Alessandra MerliniMartina RabinoSilvia BruscoValeria PaveseDebora MasciDario SangioloPaolo BironzoGiorgio Vittorio ScagliottiSilvia NovelloLorenzo D ’Ambrosioa Department of Oncology, University of Turin, Orbassano (TO), Italyb Division of Molecular Pat Source Type: research
Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 18, 2024 Category: Drugs & Pharmacology Authors: Lin ChenTian FanMiao WangChun-Yu ZhuWang-You FengYu LiHong Yanga Department of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi ’an, Chinab Laboratory of Cell Biology, Institute of Medical Research, Northwestern Polytec Source Type: research
Mitochondrial permeability transition pore: a snapshot of a therapeutic target
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 18, 2024 Category: Drugs & Pharmacology Authors: Mario ZorattiLucia BiasuttoSofia ParrasiaIldik ó Szaboa CNR Neuroscience Institute, Padova Unit, Padova, Italyb Department Biomedical Sciences, University of Padova, Padova, Italyc Department Biology, University of Padova, Padova, Italy Source Type: research
Cytokines of the interleukin-6 family as emerging targets in inflammatory bowel disease
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - January 13, 2024 Category: Drugs & Pharmacology Authors: Christoph GarbersJuliane LokauInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany Source Type: research
How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?
Volume 27, Issue 12, July - December 2023, Page 1189-1194 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Paolo BaldoValli De ReMattia Garuttia Hospital Pharmacy Unit, Centro di Riferimento Oncologico di Aviano, CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italyb Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano, Source Type: research
Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study
Volume 27, Issue 12, July - December 2023, Page 1177-1188 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Jessica D. JohnsonSalvador AlejoSridharan JayamohanGangadhara R. Sareddya Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, TX, USAb Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA Source Type: research
Unraveling therapeutic targets in acute myeloid leukemia through multiplexed genome editing CRISPR screening
Volume 27, Issue 12, July - December 2023, Page 1173-1176 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Zhen TianStacia OctavianiJian Huanga Coriell Institute for Medical Research, Camden, NJ, USAb Center for Metabolic Disease Research, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USAc Cooper Medical School of Rowan University, Camden, Source Type: research
Novel signatures of prostate cancer progression and therapeutic resistance
Volume 27, Issue 12, July - December 2023, Page 1195-1206 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Jason WangReuben Ben-DavidReza MehrazinWei YangAshutosh K. TewariNatasha Kyprianoua Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USAb The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAc Source Type: research
Targeting GABA receptors with chalcone derivative compounds, what is the evidence?
Volume 27, Issue 12, July - December 2023, Page 1257-1269 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Feba BennySunil KumarAiswarya BinuDella Grace Thomas ParambiTariq G. AlsahliAbdullah G. Al-SehemiNamitha ChandranDeepthi S. ManishaSarath SreekumarAkanksha BhattKrishnadas MadhuBijo Mathewa Department of Pharmaceutical Chemistry, Amrita School of Pharmacy Source Type: research
Advances in targeting the extracellular matrix for glaucoma therapy: current updates
Volume 27, Issue 12, July - December 2023, Page 1217-1229 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Renu AgarwalIgor IezhitsaSchool of Medicine, International Medical University, Kuala Lumpur, Malaysia Source Type: research
XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma
Volume 27, Issue 12, July - December 2023, Page 1207-1215 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Zahra HendiPedram Asadi SarabiDavid HayMassoud Vosougha Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iranb Dep Source Type: research
Navigating the landscape of psoriasis therapy: novel targeted pathways and emerging trends
Volume 27, Issue 12, July - December 2023, Page 1247-1256 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 30, 2023 Category: Drugs & Pharmacology Authors: Srinath InnaniYashika TomarVikas RanaGautam Singhvia Industrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, Indiab Department of Pharmaceutical Sciences and Drug Research, Punjabi unive Source Type: research
